GP Laughed at Woman Suffering from Debilitating Hormonal Condition
A Derbyshire woman has revealed how her GP laughed at her when she sought help for a debilitating premenstrual condition that causes "uncontrollable rage" and severe psychological symptoms. Laura Nicholson, 45, is now speaking out to raise awareness about premenstrual dysphoric disorder (PMDD), a severe hormone-based mood condition that impacts approximately one in twenty individuals who menstruate.
"I Needed a Padded Cell": The Reality of Living with PMDD
"There were times I needed a padded cell for a few days, that's how it felt," Ms Nicholson confessed. "I can see myself doing things, I can see myself saying things, but I just can't get myself back. It's horrible." The mother-of-one knew she required urgent medical assistance when she began experiencing intense, uncontrollable rage that made her fear for the safety of her husband and son.
Her symptoms significantly worsened following the birth of her child, who is now eleven years old. "It all came flooding back, and it was worse," she explained. "I said to my husband, 'I've got to do something about this.'" However, when she visited her general practitioner for guidance, she was met with mockery rather than medical support.
Medical Dismissal and Self-Advocacy
"I turned round to him, between sobs, and said: 'I'm glad you think it's funny,'" Ms Nicholson recalled of the distressing consultation. Following this encounter, she was eventually referred to a specialist women's health unit where she finally received appropriate diagnosis and treatment.
While acknowledging that GPs cannot be experts in every medical field, Ms Nicholson emphasized that healthcare professionals need to listen more attentively and believe women when they report abnormal symptoms. "You have to leave your dignity at the door and pick it up on your way out," she advised other women advocating for themselves in GP surgeries. "At the time you think you're the only one going through it, you're not."
Understanding Premenstrual Dysphoric Disorder
PMDD causes debilitating psychological symptoms during the luteal phase of the menstrual cycle, spanning from ovulation to the onset of the next period. Considered a severe form of premenstrual syndrome, the condition is hormone-related though its exact causes remain incompletely understood. Common symptoms include homicidal and suicidal thoughts, intense rage, profound self-hatred, and a strong desire to withdraw from social interactions.
According to data from the International Association for Premenstrual Disorders charity, seventy-two percent of PMDD sufferers experience suicidal ideation, while thirty-four percent will attempt to take their own lives. Ms Nicholson noted she has not personally experienced these particular symptoms but remains determined to continue treatment to prevent her involuntary behavior from impacting her family.
"I don't want my child growing up thinking that his mum's a monster," she stated. "I don't want my husband living through domestic violence."
Treatment Pathways and Systemic Challenges
Ms Nicholson manages her symptoms through a combination of hormonal treatment—injections that halt ovarian estrogen production followed by medication to reintroduce it—and what she describes as a "healthy obsession" with exercise. This approach has allowed her to avoid antidepressants, though she acknowledges many PMDD patients do utilize them. The injections have provided her with a "new lease of life," and she is currently awaiting a hysterectomy to further alleviate her symptoms.
A recent report from the Women and Equalities Committee highlighted how stigma, insufficient understanding, and "medical misogyny" contribute to women with gynaecological conditions facing dismissal in medical settings. Many wait years for proper diagnosis and effective treatment, with PMDD patients currently experiencing an average twelve-year diagnostic delay.
Advocacy and Policy Responses
Phoebe Williams, twenty-nine, established the PMDD Project charity in 2024 to raise awareness and support for the condition. The organization has been instrumental in securing recognition of PMDD as a serious medical condition under the renewed Women's Health Strategy, which Ms Williams hopes will represent a "turning point" for affected individuals. "Knowledge can give people hope," she affirmed.
Researchers Dr Julie Riddell and Dr Lynsay Matthews from the University of St Andrews have developed the UK Research Agenda for PMDD, establishing key priorities for future work on the condition. A spokesperson from the Department of Health and Social Care acknowledged historical failures: "Women with PMDD have been failed for far too long. Too often their symptoms are dismissed or normalised, and that has to change."
The renewed Women's Health Strategy promises to ensure women are listened to from their first appointment and directed to appropriate professionals through a single access referral point. The strategy also commits to improving collaboration between mental health and women's health sectors to better understand the links between female hormones and mental health.
An NHS spokesperson reinforced this commitment: "Dismissive behaviour toward any patient is unacceptable and the NHS is clear that women's symptoms must always be taken seriously." The health service is collaborating with the government to implement the Women's Health Strategy, ensuring conditions like PMDD are never overlooked through integrated care approaches.
